Enteral Feeding Formula Market By Product Type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Enteral Feeding Formula Market
Enteral Feeding Formula Market: By Product Type (Standard Formula & Disease Specific Formulas); By Application (Oncology, Gastroenterology, Neurology, Critical Care & Others); & By Region-Forecast (2017-2022)
Report Code : HCR 0288
Published: 21 August, 2017  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Patients who are unable to eat require long-term nutritional support; hence the patients are provided nutrition with help of feeding tubes. Premature infants to the elderly patients who are survivors of strokes, suffering from chronic conditions including cancer or head trauma require these enteral feeding formula as their life line support. As enteral feeding formulas are rich in protein, fiber and calories, these provide the patient proper nutrition for their survival. Owing to rise in number of chronic disease patients, rapid aging population and surging prevalence of preterm birth; the market is projected to grow significantly during the forecast period. Escalating demand for home based treatment and services for elderly patients are other driving factors for enteral feeding formula market.

The enteral feeding formula market has been broadly studied based on numerous differentiating parameters to provide a comprehensive overview. The market has been categorized on basis of product type, therapeutic area and geography. By therapeutic area, the market has been divided into Oncology, Gastroenterology, Neurology and few more. On the basis of geography, the market has been segmented into Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).



Americas region led the enteral feeding formula market in 2016. Rising geriatric population and growing chronic disease patients in this region had elevated the growth of the market. High consumption of tobacco products causing oral cancer and rapidly increasing aging population suffering from paralysis are the key drivers for growth of the market in APAC.

Sample Companies Profiled in this Report are:
  • Abbott Laboratories (U.S.)
  • Danone S.A. (France)
  • Nestle S.A. (Switzerland)
  • Fresenius Kabi AG (Germany)
  • Mead Johnson Nutrition (U.S.).
  • 10+ 

These companies with innovative product launches and large investment in R&D department have acquired global market shares.
1.Enteral Feeding Formula Market Overview
2.Enteral Feeding Formula Market Executive Summary
3.Enteral Feeding Formula Market Landscape 
   3.1.Market Share Analysis
   3.2.Product Benchmarking
   3.3.Patent Analysis
   3.4.End User Profiling
   3.5.Comparative Analysis
4.Enteral Feeding Formula Market Forces
   4.1.Market Drivers
      4.1.1.Rising Prevalence of Chronic Diseases
      4.1.2.Increasing Need for Home Healthcare
      4.1.3.Aging Population
      4.1.4.Preferred Clinical Nutrition
   4.2.Market Constraints & Challenges
      4.2.1.High R&D Expenditures
      4.2.2.Stringent Regulations
   4.3.Attractiveness of Enteral Feeding Formula Market
      4.3.1.Power of Suppliers
      4.3.2.Power of Buyers
      4.3.3.Threat of Substitutes
      4.3.4.Threat of New entrants
      4.3.5.Degree of Competition
5.Enteral Feeding Formula Market – Strategic Analysis
   5.1.Value Chain Analysis
   5.2.Pricing Analysis
   5.3.Opportunities Analysis
   5.4.Market Life Cycle Analysis
6.Enteral Feeding Formula Market, By Product Type
   6.1.Standard formula
   6.2.Disease specific formulas
7.Enteral Feeding Formula Market, By Therapeutic Area
   7.1.Oncology
   7.2.Gastroenterology
   7.3.Neurology
   7.4.Critical care
   7.5.Others
8.Enteral Feeding Formula Market - By Geography
   8.1.Introduction
   8.2.Americas
      8.2.1.US 
      8.2.2.Canada
      8.2.3.Mexico
      8.2.4.Brazil
      8.2.5.Rest Of Americas
   8.3.Europe
      8.3.1.U.K
      8.3.2.France
      8.3.3.Germany
      8.3.4.Spain
      8.3.5.Rest of Europe
   8.4.Asia Pacific
      8.4.1.China
      8.4.2.Japan
      8.4.3.India
      8.4.4.Rest of Asia Pacific
   8.5.RoW
      8.5.1.Middle East 
      8.5.2.Africa
9.Enteral Feeding Formula Market Entropy
10.Enteral Feeding Formula Market Company Profiles 
   10.1.Nestle S.A. (Switzerland)
   10.2.B.Braun Melsungen AG (Germany)
   10.3.Merck & Co., Inc. (U.S.)
   10.4.Meiji Holdings Co., Ltd. (Japan)
   10.5.Global Health Product Inc. (U.S.)
   10.6.Victus Inc. (U.S.)
   10.7.Abbott Laboratories (U.S.)
   10.8.Alcresta Therapeutics, Inc. (U.S.)
   10.9.Baxter International,Inc.  (U.S.)
   10.10.Danone S.A. (France)
   10.11.Fresenius Kabi AG (Germany)
   10.12.Mead Johnson Nutrition Company (U.S.)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
LIST OF TABLES:

Table 1: Global Enteral Feeding Formula Market Value, By Geography, 2015-2022 ($Billion) 
Table 2: Americas Enteral Feeding Formulas Market Value, By Country, 2015-2022 ($Billion) 
Table 3: Americas Enteral Feeding Formulas Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 4: Americas Enteral Feeding Formulas Market Value, By Product Type, 2015-2022 ($Billion)
Table 5: Europe Enteral Feeding Formulas Market Value, By Country, 2015-2022 ($Billion) 
Table 6: Europe Enteral Feeding Formulas Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 7: Europe Enteral Feeding Formulas Market Value, By Product Type, 2015-2022 ($Billion)
Table 8: Asia-Pacific: Enteral Feeding Formula Market Value, By Country, 2015-2022 ($Billion) 
Table 9: Asia-Pacific: Enteral Feeding Formula Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 10: Asia-Pacific: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion)
Table 11: RoW: Enteral Feeding Formula Market Value, By Country, 2015-2022 ($Billion) 
Table 12: RoW: Enteral Feeding Formula Market Value, By Therapeutic Area, 2015-2022 ($Billion)
Table 13: RoW: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion)


LIST OF FIGURES:

Figure 1: Global Enteral Feeding Formula Market Value ($Billion) & Volume (KT), 2015-2022 
Figure 2: Global Enteral Feeding Formula Market Revenue, By Geography, 2015-2022 ($Billion) 
Figure 3: Global Enteral Feeding Formula Market Value Share, By Product Type, 2015 (%)
Figure 4: Global Enteral Feeding Formula Market Value Share, By Therapeutic Area, 2015 (%)
Figure 5: Global Enteral Feeding Formula Market Value, By Geography, 20,152,021 ($Million) 
Figure 6: Global Enteral Nutrition Market Share, 2016 (%) 
Figure 7: Global Clinical Nutrition Market Share, 2016 (%) 
Figure 8: Enteral Feeding Formula Patents, 2012-2016* 
Figure 9: Enteral Feeding Formula Market Share, By Therapeutic area, 2015 (%) 
Figure 10: EPS Representation: By Company, 2013-2015 ($) 
Figure 11: Bargaining Power of Suppliers – Enteral Feeding Formula Market 
Figure 12: Bargaining Power of Buyers – Enteral Feeding Formula Industry 
Figure 13: Threat from Substitutes – Enteral Feeding Formula Industry 
Figure 14: Threat from New Entrants – Enteral Feeding Formula Industry 
Figure 15: Enteral Feeding Formula Industry – Attractiveness 
Figure 16: Enteral Feeding Formula Market Value, By Product Type, 2015-2022 ($Billion) 
Figure 17: Standard Formula: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 18: Disease Specific Formula: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 19: Global Enteral Feeding Formula Market Revenue, By Therapeutic Area, 2015-2022 ($Billion) 
Figure 20: Oncology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 21: United States: Digestive Disease Statistics, By Hospitalizations, By Mortality, 2010 
Figure 22: Gastroenterology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 23: Neurology: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 24: Critical Care: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 25: Others: Global Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 26: U.S.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 27: U.S.: GDP – Composition of 2015, By Sector of Origin 
Figure 28: U.S.: Export and Import Value, 2012-2015 ($Trillion) 
Figure 29: U.S.: GDP – Composition of 2015, By End Use 
Figure 30: U.S.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 31: Canada: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 32: Canada: GDP – Composition of 2015, By Sector of Origin 
Figure 33: Canada: Export and Import Value, 2012-2015 ($Billion) 
Figure 34: Canada: GDP – Composition of 2015, By End Use 
Figure 35: Canada: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 36: Total Number of ICU Admission in Canada 
Figure 37: Mexico: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 38: Mexico: GDP – Composition of 2015, By Sector of Origin 
Figure 39: Mexico: Export and Import Value, 2012-2015 ($Billion) 
Figure 40: Mexico: GDP – Composition of 2015, By End Use 
Figure 41: Mexico: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 42: Brazil: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 43: Brazil: GDP – Composition of 2015, By Sector of Origin 
Figure 44: Brazil: Export and Import Value, 2012-2015 ($Billion) 
Figure 45: Brazil: GDP – Composition of 2015, By End Use 
Figure 46: Brazil: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 47: Rest of Americas: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 48: U.K.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 49: U.K.: GDP – Composition of 2015, By Sector of Origin 
Figure 50: U.K.: Export and Import Value, 2012-2015 ($Billion) 
Figure 51: U.K.: GDP – Composition of 2015, By End Use 
Figure 52: U.K.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 53: Germany: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 54: Germany: GDP – Composition of 2015, By Sector of Origin 
Figure 55: Germany: Export and Import Value, 2012-2015 ($Billion) 
Figure 56: Germany: GDP – Composition of 2015, By End Use 
Figure 57: Germany: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 58: Spain: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 59: Spain: GDP – Composition of 2015, By Sector of Origin 
Figure 60: Spain: Export and Import Value, 2012-2015 ($Billion) 
Figure 61: Spain: GDP – Composition of 2015, By End Use 
Figure 62: Spain.: Enteral Feeding Formulas Market, 2015-2022 ($Billion) 
Figure 63: Spain: Population ages 65 and above (% of total) 
Figure 64: France: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 65: France: GDP – Composition of 2015, By Sector of Origin 
Figure 66: France: Export and Import Value, 2012-2015 ($Billion) 
Figure 67: France: GDP – Composition of 2015, By End Use 
Figure 68: France: Enteral Feeding Formulas Market,2015-2022 ($Billion) 
Figure 69: France: Population ages 65 and above (% of total) 
Figure 70: Total Percentage of the Elderly Population, By Country, 2015 
Figure 71: Rest of Europe: Enteral Feeding Formulas Market,2015-2022 ($Billion) 
Figure 72: China: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 73: China: GDP – Composition of 2015, By Sector of Origin 
Figure 74: China: Export and Import Value, 2012-2015 ($Billion) 
Figure 75: China: GDP – Composition of 2015, By End Use 
Figure 76: Oral Cavity Cancer Incidence in China, 2010 
Figure 77: China: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 78: Japan: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 79: Japan: GDP – Composition of 2015, By Sector of Origin 
Figure 80: Japan: Export and Import Value, 2012-2015 ($Billion) 
Figure 81: Japan: GDP – Composition of 2015, By End Use 
Figure 82: Number of Cancer Incidence by Age and Site(2011) 
Figure 83: Japan: Population ages 65 and above (% of total) 
Figure 84: Japan: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 85: India: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 86: India: GDP – Composition of 2015, By Sector of Origin 
Figure 87: India: Export and Import Value, 2012-2015 ($Billion) 
Figure 88: India: GDP – Composition of 2015, By End Use 
Figure 89: India: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 90: Trends in cancer incidence rates from 1999 to 2012 in Korea 
Figure 91: Rest of APAC: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 92: Middle East: Enteral Feeding Formula Market Value, 2015-2022 ($Billion) 
Figure 93: Africa: Enteral Feeding Formula Market Value,2015-2022 ($Billion) 
Figure 94: Enteral Feeding Formula Market Entropy Share, By Strategies, 2012-2016* (%) 
Figure 95: Enteral Feeding Formula Market Entropy, By Total Number of Developments, 2012-2016* 
Figure 96: Nestle S.A.: Sales, by years 2013 – 2015 ($Billion) 
Figure 97: Nestle S.A.: Sales, by Operating segments, 2015 (%) 
Figure 98: Nestle S.A.: Sales, by Geography, 2015 (%) 
Figure 99: Merck & Co., Inc. , Net sales, By Years, 2013-2015 ($Billion) 
Figure 100: Merck & Co., Inc., Revenue Share,By Business Segment, 2015(%) 
Figure 101: Merck & Co., Inc., Revenue Share,By Geography, 2015(%) 
Figure 102: Meiji Holdings Co., Ltd., Net Sales, 2012-2016 ($B) 
Figure 103: Meiji Holdings Co., Ltd., Net Sales, By Business Segment, 2016 (%) 
Figure 104: B.Braun Melsungen AG Revenue, 2013-2015 ($Billion) 
Figure 105: B.Braun Melsungen AG Revenue Share, By Business Segment, 2015 (%) 
Figure 106: B.Braun Melsungen AG Revenue Share, By Geography, 2015 (%) 
Figure 107: Abbott Laboratories, Revenue, 2013-2015 ($Billion) 
Figure 108: Abbott Laboratories, Revenue, By Business Segment, 2015 (%) 
Figure 109: Abbott Laboratories, Revenue, By Region, 2015 (%) 
Figure 110: Baxter International Inc. , Net sales, By Years, 2013-2015 ($Billion) 
Figure 111: Baxter International Inc., Revenue Share, By Business Segment, 2015(%) 
Figure 112: Baxter International Inc., Revenue Share, By Geography, 2015(%) 
Figure 113: Danone, Revenue, 2013-2015 ($Million) 
Figure 114: Danone, Revenue, By Business Segment, 2015 (%) 
Figure 115: Danone, Revenue, By Region, 2015 (%) 
Figure 116: Fresenius Kabi AG Sales, 2013-2015 ($Billion) 
Figure 117: Fresenius Kabi AG Sales, By Business segments, 2015 (%) 
Figure 118: Fresenius Kabi AG Revenue Share, By Geography, 2015 (%) 
Figure 119: Mead Johnson Nutrition Company Net Sales, 2012-2015 ($Billion) 
Figure 120: Mead Johnson Nutrition Company Net Sales Share, By Geography, 2015 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll